search
Company Information
USD
42.97
- (-0.09%)
NASDAQ:CRNX, CRINETICS PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 19 April 2024 GMT-4
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Address

6055 Lusk Boulevard

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Matthew K. Fust
Director
Dr. Wendell D. Wierenga,PhD
Chairman of the Board/Director
Dr. Camille L. Bedrosian,M.D.
Director
Dr. Rogerio Vivaldi Coelho, M.D.
Director
Mr. Marc J.S. Wilson
CFO/Chief Accounting Officer
Ms. Stephanie S. Okey, M.S.
Director
Dr. R. Scott Struthers, PhD
CEO/Co-Founder/Director/President
Dr. Weston Nichols, PhD
Director
Ms. Caren Deardorf
Director
Dr. Alan Krasner,M.D.
Chief Medical Officer
Dr. Stephen F. Betz, PhD
Chief Scientific Officer/Co-Founder
Mr. James Hassard
Other Executive Officer
Dr. Dana Pizzuti, M.D.
Other Executive Officer
Mr. Jeff E. Knight
COO

Ownership

Institution Holdings

BlackRock Inc
5,345,114 (7.680%)
Driehaus Capital Management LLC
5,039,957 (7.242%)
Point72 Asset Management, L.P.
4,225,300 (6.071%)
FMR Inc
4,043,865 (5.810%)
State Street Corporation
3,563,736 (5.121%)
Vanguard Group Inc
3,502,452 (5.033%)
Wellington Management Company LLP
3,245,105 (4.663%)
Wellington Management Group, LLP
3,245,105 (4.663%)
T. Rowe Price Associates, Inc.
3,008,858 (4.323%)
BlackRock Fund Advisors
2,947,299 (4.235%)

Individual Holdings

Dr. R. Scott Struthers, PhD
250,522 (0.322%)
Dr. Wendell D. Wierenga,PhD
105,846 (0.196%)
Mr. Marc J.S. Wilson
121,555 (0.156%)
Dr. Stephen F. Betz, PhD
96,298 (0.124%)
Mr. Jeff E. Knight
59,222 (0.076%)
Dr. Alan Krasner,M.D.
43,210 (0.065%)
Mr. James Hassard
31,000 (0.040%)
Dr. Dana Pizzuti, M.D.
28,911 (0.037%)
Mr. Matthew K. Fust
18,536 (0.034%)
Dr. Rogerio Vivaldi Coelho, M.D.
11,000 (0.020%)

Funds Holdings

SPDR® S&P Biotech ETF
2,293,920 (3.296%)
Vanguard Total Stock Market Index Fund
1,974,575 (2.837%)
Vanguard US Total Market Shares ETF
1,974,575 (2.837%)
iShares Russell 2000 ETF
1,589,181 (2.283%)
T. Rowe Price New Horizons Fund
1,329,330 (1.910%)
US Small-Cap Growth II Equity Comp
1,329,330 (1.910%)
Eventide Healthcare & Life Sciences Fund
1,059,633 (1.523%)
Vanguard Institutional Extnd Mkt Idx Tr
851,141 (1.223%)
Bridge Builder Small/Mid Cap Growth Fund
816,532 (1.173%)
T. Rowe Price Small-Cap Stock Fund
783,032 (1.125%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices